Reversible brain edema associated to flow diverter stent procedures: a retrospective single-center study to evaluate frequency, clinical evolution, and possible mechanism by Narata, A.P. et al.
This is a repository copy of Reversible brain edema associated to flow diverter stent 
procedures: a retrospective single-center study to evaluate frequency, clinical evolution, 
and possible mechanism.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/138918/
Version: Accepted Version
Article:
Narata, A.P., Janot, K., Bibi, R. et al. (4 more authors) (2018) Reversible brain edema 
associated to flow diverter stent procedures: a retrospective single-center study to 
evaluate frequency, clinical evolution, and possible mechanism. World Neurosurgery. ISSN
1878-8750 
https://doi.org/10.1016/j.wneu.2018.10.103
Article available under the terms of the CC-BY-NC-ND licence 
(https://creativecommons.org/licenses/by-nc-nd/4.0/).
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
	
	

	
				

		 !		
"		#"$!	

%
&	$$'(	$$%
$$)	$$
%$!	$%$	*$%$(%!		$$%
++ ,-.--./01,-23450,6
7+ %		88
9 8,09,0,:8;9940,-9,09,03
< =&>,0/5.
? World Neurosurgery

	 30 	40,-

	 ,57	40,-
	
	 ,:7	40,-
		%	&	$(	'$$)	$	!$*$!		($

	
				
		 !	
	
"		#"$!	
%$	
140,-2$

%		88
9 8,09,0,:8;9940,-9,09,039
?%<<
	
		%	%	
<	9	
	
 	%"<	%	9?%	
 
"
	 $	"		 $
<	%	 <<	%
	<<9
		%	
 	%
	"

%%
<<		%		$

 
	%	"		%;	9
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
Reversible Brain Edema Associated to Flow Diverter Stent Procedures: A Retrospective 
Single Center Study to Evaluate Frequency, Clinical Evolution and Possible Mechanism 
   
Ana Paula Narata1, MD; Kevin Janot1, MD; Richard Bibi1, MD; Denis Herbreteau1, MD, 
PhD; Cecile Perrault2, PhD; Alberto Marzo2, PhD; Jean-Philippe Cottier1, MD, PhD 
 
1Department of Radiology and Neuroradiology, University Hospital of Tours, France 
2Mechanical Engineering Department, University of Sheffield, United Kingdom  
 
Previous presentation: ISC 2018, Los Angeles, CA, poster presentation on January 25th 
2018. 
 
Disclosure of funding: authors certify that they have no affiliations with or involvement in 
any organization or entity with any financial interest (such as honoraria, educational grants, 
participation in speaker’s bureaus, membership, employment, consultancies, stock ownership 
or other equity interest, and expert testimony or patent-licensing arrangements) or non-
financial interest (such as personal or professional relationship, affiliations, knowledge or 
beliefs) in the subject matter or materials discussed in this manuscript; authors confirmed that 
this study did not receive any financial support from public organizations or private 
companies.    
 
Corresponding author: 
Dr. Ana Paula Narata 
Department of Radiology and Neuroradiology 
University Hospital of Tours 
2 Boulevard Tonnelle 
37044 Tours 
France 
Phone: +33247479703 
FAX: +33247478491 
E-mail: apnarata@gmail.com 
 
RUNNING TITLE: Brain Edema After Flow Diverter Stent 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
KEY WORDS: brain edema, flow diverter stent, intracranial aneurysm 
 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
ABSTRACT 
         
         BACKGROUND: hemorrhage and ischemia after flow diverter stent (FDS) procedures 
for intracranial aneurysms are the most common complications and have been extensively 
described. Temporary brain edema (TBE) is an unknown complication that could be 
associated to particular FDS procedures.  
 
OBJECTIVE: to estimate frequency, clinical presentation, imaging finding and 
possible mechanisms associating TBE and FDS. 
 
METHODS: unruptured aneurysms treated with FDS implantation performed in our 
service from June 2015 to March 2018 were reviewed. Medical antecedents, endovascular 
procedure, pre and post treatment clinical assessment, aneurysm characteristics and image 
records were collected. Artery diameters of patients developing TBE were also calculated in 
order to investigate any correlation between TBE and anatomical descriptors.  
 
RESULTS: total of 179 FDS in 176 patients were reviewed. Six patients (3.4%) 
presented with symptomatic TBE and all TBE patients had undergone FDS implantation from 
middle cerebral artery (MCA) to the internal carotid artery (ICA). Pearson Product-Moment 
Correlation Coefficient (PPCC) found smaller MCA diameter and ratio MCA/ICA in these 6 
patients (respectively PPCC= -0.619,p<0.04 and PPCC= -0.647,p<0.03). Hemorrhagic and 
ischemic complications were less frequent than TBE (2.3% and 1.1% versus 3.4%).  
 
CONCLUSIONS: TBE was more frequent than ischemic or hemorrhagic 
complications after FDS in this study. It seems to be associated to a particular FDS 
positioning in small arteries, inducing flow changes and BBB disruption.  
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INTRODUCTION 
 
Flow diverter stenting (FDS) is a relatively recent technique that has been used in the 
treatment of intracranial aneurysms with high aneurysm occlusion rates. Morbidity and 
mortality related to procedure were respectively 5% and 4% in a meta-analysis study, 
however ischemic spots could be found in diffusion-weight imaging (DWI) in more than 80% 
of asymptomatic patients compared to symptomatic ischemic thromboembolic lesions being 
estimated to 6%1,2. Global ischemic complications are estimated from 1.7 to 5.6 % with a 
lowest rate recently described when aspirin is associated to ticagrelor3. Hemorrhagic 
complications were described in 3 to 4.3% of studies, with high morbidity and mortality rates 
for massive intra-parenchymal hemorrhage (50% and 45%) with delayed onset3,4.  
Temporary brain edema (TBE) after FDS is an unknown complication with very few 
cases in the literature. Some brief reports described few patients that presented brain edema 
after FDS procedure associated to neurological impairment. Brain edema and neurologic 
symptoms seem to disappear in few days without permanent lesions. Chiu AH et al. described 
1 patient where FDS could increase blood flow when covering a large aneurysm neck and 
create a hyperperfusion syndrome5. In a series of 66 aneurysms treated with FDS in 59 
patients, 2 patients (3.4%) presented TBE after a treatment of large aneurysms. Magnetic 
resonance imaging (MRI) did not show ischemia, hemorrhage or hyperperfusion in perfusion 
MRI (PWI).  Symptoms started by neurological impairment few hours after procedure and 
completely disappeared in some days. MRI follow up of patients presenting TBE became 
normal after 1 week. The hypothesis to explain this phenomenon was the higher blood flow in 
the parent vessel redirected by the FDS that could consist in an increased risk of hemorrhagic 
complication. TBE (3.4%) was comparable to ischemic and hemorrhagic complications rates 
described in the literature6. 
Considering that TBE might be underestimated, the potential tendency for hemorrhagic 
transformation and unknown mechanism, this study reviewed our experience with FDS since 
June 2015 looking for patients who developed TBE. Imaging analysis, clinical presentation 
and evolution were analyzed in this study in order to observe frequency and discuss possible 
mechanisms of TBE.  
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METHODS 
 
Patient Selection and Clinical Data Collection 
Patients with unruptured intracranial aneurysms, pre-operative computed tomography 
(CT) or MRI and treated with FDS in our institution from June 2015 to March 2018 were 
retrospectively reviewed. Patients with ruptured aneurysms and treated with FDS were 
excluded to avoid any influence of subarachnoid hemorrhage on TBE estimation. Institutional 
Review Board approval was obtained without necessity of consent for retrospective and 
anonymous data collection. Endovascular techniques, imaging data, clinical evaluation at 
baseline/during hospitalization and at 3 months were collected.  
Patients who developed severe headache and/or neurologic impairment associated to 
brain swelling findings on CT and MRI were identified as patients with TBE and separately 
analyzed.  
 
Stent Procedure 
Patients received double anti-platelet therapy with aspirin 160 mg associated to 
ticagrelor 90 mg twice per day; heparin was used only during intervention. FDS procedures 
were conducted under general anesthesia and fluoroscopy with a biplane X-ray system 
(General Electric Healthcare Innova IGS 650, MA, USA) using contrast agent (Iopamiron 
300, Guerbet, France) for standard angiography acquisitions. Co-axial access was composed 
by 8F long sheath and 5F/6F intermediate catheter. 3 different FDS are present in this study 
and were deployed following standard techniques. Devices and catheters are listed in 
Supplemental Table 1. 
 
          Image Review and Statistical Analysis  
All patients who presented severe headaches and/or neurological impairment were 
investigated with a T with dual-energy reconstruction to eliminate hemorrhage immediately 
after symptoms onset and MRI in the following hours. Patients investigated by MRI protocol 
including at least DWI, fluid-attenuated inversion recovery imaging (T2FLAIR) and time of 
flight imaging (3D-TOF) were included. MRI at 3 months follow-up was performed on all 
patients. PWI and CT perfusion (PCT) were analyzed when available. 
For all patients who developed TBE, CT and MRI images were performed in acute 
phase and at 3 months follow-up. 3 independent neuroradiologists (JPC, KJ, APN) analyzed 
all imaging records. The same neuroradiologists performed additional analysis for patients 
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with a FDS between middle cerebral artery (MCA) and internal carotid artery (ICA) by 
measuring 3 artery diameter: distal ICA, proximal MCA (M1) and proximal anterior cerebral 
artery (ACA-A1) in a 3D rotational angiography imaging performed using Osirix 
(http://www.orisix-viewer.com) before the stent procedure, reporting its arithmetic average 
value and their standard deviation to quantify interobserver variability. Reliability of these 
measures was assessed with two-way, mixed intraclass correlation coefficients (ICC) showing 
high reliability (ICC=0.992, 95% CI 0.989 to 0.995). Pearson Product-Moment Correlation 
Coefficient (PPCC) was used to identify links between clinical outcome and anatomical 
descriptors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
RESULTS 
 
Patient Population, Complications and Aneurysms Characteristics 
A total of 176 patients with unruptured aneurysms in 179 FDS procedures were 
reviewed (3 patients presented bilateral ICA aneurysms). Ischemic complications were 
observed in 2 patients (1.1%) and hemorrhagic in 4 patients (2.3%). During 3 months follow-
up period, 3 patients (1.7%) died after hemorrhagic complications (1 subdural hematoma and 
2 massive sub-arachnoid hemorrhage). Aneurysms were mostly located in the ICA (93.3%) 
and measuring less than 10 mm (53.6%). Supplemental Table 2 shows a database overview.  
 
TBE Population: General Characteristics, Clinical Evaluation and Image Analysis  
Six patients (3.4%) presented with symptomatic temporary brain edema from 176 
patients reviewed. All of them developed symptoms in the first 24h after intervention and 
lasted maximum 72h. FDS was implanted from MCA to ICA in these 6 patients (Figure 1). 
The same stent positioning was present in 5 other patients who did not develop any symptom. 
Separate analysis of these 11 patients suggests that no demographic data, aneurysm 
characteristics, endovascular material/device or medical antecedents could predict TBE 
(Supplemental Table 3). However, PPCC showed significant correlation between TBE and 
artery diameter: M1/ICA ratio (PPCC= -0.647, p<0.03) and M1 diameter (PPCC= -0.619, 
p<0.04) were smaller in the group of patients who developed brain swelling (Table 1, Figure 
2). 
CT showed sulcal effacement and subarachnoid contrast enhancement in MCA and 
ACA territories. No restriction sign on DWI or abnormalities in perfusion tests confirmed that 
no ischemic lesion is been constituted. Hemorrhagic complications, in particularly 
subarachnoid hemorrhage, were excluded with dual-energy CT and T2FLAIR. Sulcal 
effacement (brain edema) and cortical contrast enhancement (BBB disruption) were present in 
all 6 patients based on CT images. (Figure 1 and 3). 3 months control did not show any 
reminiscent TBE lesions 
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DISCUSSION 
 
Brain Edema: Blood Brain Barrier Constitution, Hydrostatic and Osmolar 
Mechanisms 
Capillary endothelial cells, astrocytes, periocytes and epithelial basal membrane 
constitute blood brain barrier (BBB), and brain edema could be induced by an increase of 
pressure in the capillary (hydrostatic or osmolar) or toxicity on cell tights junctions7.  
Increased flow and BBB disruption were previously described in hyperperfusion 
syndrome after carotid artery stenting that normally shows mild changes in PWI8. FDS could 
change compliance of the vessel wall on MCA-ICA segment and intensify pressure waves 
transmission to distal vessels (capillary compartment) leading to BBB disruption and 
hyperperfusion syndrome. Decreased arterial elasticity could be considered as a quick 
removal of Windkessel effect: increased pressure transmitted to distal territories after FDS 
could be considered correlated to BBB disruption and brain edema9.  This viewpoint was 
already considered in the literature where decrease in Windkessel effect could partially 
explain BBB disruption and IPH after FDS10.  
Considering perfusion tests, PWI is not a quantitative exam and it is necessary to 
compare to the opposite hemisphere or previous PWI performed before treatment to precisely 
confirm a status of hyperperfusion11. From these 6 patients with brain edema, we performed 
PWI or PCT in only 3 patients, and no patient presented clear perfusion asymmetry when 
compared to the opposite side. Considering brain edema in a very early beginning, we 
observed sulcal effacement and contrast enhancement in all 6 patients using CT images. MRI 
with gadolinium injection (when performed) could also demonstrated contrast enhancement, 
but MRI was mostly performed to exclude ischemic lesions.  
Looking at studies describing unilateral TBE after endovascular procedures without 
ischemic lesions, we found similar CT images in contrast neurotoxicity reports after 
endovascular procedures. Mechanism of brain edema is probably related to increased 
osmolality, toxicity by the iodine atoms and/or BBB permeability. General clinical 
presentation is also similar: neurologic impairment onset is immediate or some hours after 
intervention (headaches and neurologic impairment in 12-24 hours in our study), benign 
evolution over few days with CT normalization12. Quantity of low osmolar contrast should 
respect 5ml/kg of patient weight and inferior to 300 ml/intervention, and we observed 
maximum 3mg/kg and 210ml in the study. Neurotoxicity incidence varies from 0.3-1% and 
we found 3.4% of patients with brain edema13. However, presence of contrast enhancement in 
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this study is very similar to previous published reports of contrast neurotoxicity that could 
suggest that probably a hemodynamic process caused disruption in the BBB (without 
hyperperfusion syndrome) and facilitated contrast penetration, as quantity and contrast density 
were respected14. 
 
FDS Positioning, Arteries Diameter and Flow Disruption 
FDS placed from MCA to ICA was associated with brain edema in 6 patients, 5 patients 
with same FDS positioning did not develop TBE. Statistic analysis of artery caliber suggests 
that brain edema was more frequent in patients with smaller MI diameter. Considering stent 
implantation as a bypass between ICA-MCA, we could consider blood flow changes being 
more sensitive in small MCA caliber with more distal impact. Flow diverted through 
significantly reducing caliber vessels amplifies Bernoulli effect (velocity increases while 
pressure decreases) leading to BBB dysfunction without hyperperfusion and contrast 
impregnation15.  
We did not identify hemorrhagic or permanent complication in the 6 patients with TBE. 
Considering that BBB was affected by flow changes, control of arterial blood flow could be 
concerned in the post-operative period. After our first 2 cases of TBE, we imposed maximum 
systolic blood pressure control similar to the protocol applied for cervical carotid stent where 
hyperperfusion syndromes were associated to hemorrhagic complications6,11,16. 
 
Limitations 
This study is a retrospective single center study that has limitations. The fact that we 
separately analyzed a specific group of 6 patients presenting neurologic impairment and TBE 
with same FDS positioning in all patients, and then we looked for common elements to 
another group of 5 patients with same stent positioning but no TBE, might have induced bias 
in our analysis. The small number of patients affected limits any conclusion about 
physiopathology and efficient clinical management.    
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SUMMARY 
 
TBE was more frequent than ischemic or hemorrhagic complications (3.4% versus 1.7% 
and 2.3% respectively) in this study and similar results to a previous study based on 59 
patients6. Analyzing separately our 6 patients, TBE seems to be associated to a particular stent 
positioning that could induce flow changes and BBB disruption, particularly in smaller 
arteries. Neurologic impairment is transitory and disappears progressively during the first 
week after procedure. We did not observe any hemorrhagic transformation whereas arterial 
blood pressure was systematically controlled. In spite of impressive findings in CT, no 
permanent lesion was found in the 3 months control images. Analyses of further similar cases 
are necessary to understand the BBB disruption mechanism after FDS and identify unsafe 
FDS positioning.  
 
CONCLUSION 
 
TBE seems to depend on FDS positioning and artery diameter. In this study, all patients 
affected by TBE were treated with a FDS placed distally in MCA and proximally in ICA, and 
also MCA diameter was smaller in patients who developed TBE. Further research will be 
necessary to confirm these preliminary findings.  
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FIGURE LEGENDS 
 
Figure 1. Recanalized left ICA aneurysm re-treated with FDS implantation from MCA 
to ICA (A, B). Patient developed severe headache and right hemiparesis 12h after 
intervention. CT showed diffuse brain swelling on left hemisphere (C) and no ischemic lesion 
on DWI (D). 
 
Figure 2. Distribution of M1diameter (A) and M1/ICA ratio (B) for swelling and no 
swelling datasets. Patients who developed transient brain edema after FDS presented smaller 
M1 diameter and M1/ICA ratio (<0.8). 
 
Figure 3. CT shows contrast enhancement on left hemisphere that could simulate 
subarachnoid hemorrhage (A). Dual-energy CT (B) and T2FLAIR (C) exclude presence of 
blood in the subarachnoid space. PWI did not show significative changes in perfusion (D). 
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TABLE 1. List of materials and devices and distribution over the patient population 
Long sheath All procedures  Brain swelling (6 patients) 
     Neuron Max, Penumbra, Alameda, USA 107 4 
     IVA, Balt, Montmorency, France 62 2 
5F/6F intermediate Catheter   
     Fargo, Balt, Montmorency, France 45 1 
     Navien, Covidien, Irvine, CA 89 3 
     Catalyst, Stryker, Freemont, CA 45 2 
FDS   
     PED, ev3/Covidien, Irvine, CA 132 3 
     Surpass, Stryker, Freemont, CA 33 2 
     P64, Phenox, Bochum, Germany 14 1 
FDS=flow diverter stent; PED=Pipeline Embolization Device. 
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TABLE 2. Demographic data, antecedents and aneurysms characteristics of 176 patients 
Sex   
     Female 102 58% 
     Male 74 42% 
Age 9-82 years old 51 years old (medium age) 
Location   
     ICA 167 93.3% 
     Basilar 3 1.7% 
     Vertebral (+PICA) 4 2.2% 
     MCA 2 1.1% 
     ACA 1 0.6% 
     PCA 2 1.1% 
Size   
     ≤10 mm 96 53.6% 
    10-20mm 80 44.7% 
     ≥20mm 3 1.7% 
Medical Antecedents   
     Diabetes 11 6.2% 
     Arterial Hypertension 52 29.5% 
     Smoke 81 46% 
     Polycistic Kidneys 1 0.5% 
Symptomatic complication rates (176 patients)   
     Ischemic  2 1.1% 
     Hemorragic 4 2.3% 
Death before 3 months  3 1.7% 
ICA=internal carotid artery; PICA=posterior inferior cerebellar artery; MCA=middle cerebral 
artery; ACA=anterior cerebral artery; PCA=posterior cerebral artery; DAPT=double 
antiplatelet therapy. 
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TABLE 3. Anatomical data of patients with FDS MCA-ICA positioning 
Patient Sex Age Location A1 (mm) M1 (mm) ICA (mm) M1/ICA A1/ICA Outcome 
1 M 36 ICA/L 1.9+0.12 2.5+0.06 3.2+0.10 0.8 0.6 swelling 
2 F 74 ICA/L 2.5+0.06 2.7+0.06 3.7+0.06 0.7 0.7 swelling 
3 M 69 ICA/L 1.9+0.12 2.5+0.10 3.3+0.10 0.8 0.6 swelling 
4 F 62 ICA/L 2.0+0.10 2.7+0.06 4.1+0.23 0.7 0.5 swelling 
5 F 47 ICA/R 1.2+0.10 2.5+0.00 2.7+0.06 0.9 0.4 no swelling 
6 F 43 Tip ICA/R 2.1+0.12 2.9+0.12 3.6+0.10 0.8 0.6 no swelling 
7 F 51 ICA/R 1.9+0.12 2.9+0.15 3.5+0.00 0.8 0.6 no swelling 
8 M 51 ICA/L 2.4+0.06 2.7+0.10 3.4+0.10 0.8 0.7 no swelling 
9 M 39 ICA/L 1.9+0.12 3.0+0.06 3.4+0.10 0.9 0.6 no swelling 
10 M 49 A1/R 2.0+0.06 2.7+0.06 3.0+0.06 0.9 0.6 swelling 
11 F 59 ICA/L 2.0+0.06 2.3+0.10 3.1+0.12 0.8 0.7 swelling 
FDS=flow diverter stent; MCA=middle cerebral artery; ICA=internal carotid artery; A1=first segment of anterior 
cerebral artery; M1=first segment of median cerebral artery; M1/ICA=ratio between M1 and ICA; A1/ICA=ratio 
between A1 and ICA; L=left side; R=right side. 
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                   TABLE 4.  Demographic data and aneurysm characteristics of patients with FDS MCA-  
                   ICA positioning 
 Brain oedema  No brain oedema  
Total of patients 6  5  
Sex     
     Female 3  3  
     Male 3  2  
Medium Age (years) 59   47   
Location     
     ICA 5  4  
     Basilar 0  0  
     Vertebral (+PICA) 0  0  
     MCA 0  0  
     ACA 1  1  
     PCA 0  0  
Size     
     ≤10 mm 3  4  
    10-20mm 2  1  
     ≥20mm 0  0  
DAPT     
     Aspirin + Clopidogrel 0  1  
     Aspirin + Ticagrelor 6  4  
Medical Antecedents     
     Diabetes 0  0  
     Arterial Hypertension 3  2  
     Smoke 2  2  
     Polycistic Kidneys 0  0  
Neurologic Symptoms     
      HE only 2  0  
      NI only 0  0  
      HE+NI  4  0  
Symptoms Onset     
     ≤12h 0  -  
     12-24h 6  -  
     ≥24h 0  -  
Symptoms Duration     
<48h 0  -  
48-72h 6  -  
Death before 3 months  0  0  
FDS=fow diverter stent; MCA=middle cerebral artery; ICA=internal carotid artery; 
PICA=posterior inferior cerebellar artery; ACA=anterior cerebral artery; PCA=posterior 
cerebral artery; DAPT=double antiplatelet therapy; HE=headache; NI=neurologic 
impairment. 
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